This differential AR expression between luminal subtypes may partially explain the different 2D:4D ratio findings in our study and suggests a deeper, more complex interaction between prenatal hormone exposure and tumor biology in Luminal A breast cancer. The gene discussed is AR; the disease is breast carcinoma.